Thompson, E., Landi, D., Archer, G., Lipp, E., Walter, A., Archambault, B., … Sampson, J. (2021). EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In Neuro-Oncology (Vol. 23, pp. i46–i46). Hynes Convention Center, Boston, MA: Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noab090.187

Thompson, Eric, Daniel Landi, Gerald Archer, Eric Lipp, Ashley Walter, Bridget Archambault, Bea Balajonda, et al. “EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In Neuro-Oncology, 23:i46–i46. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab090.187.

Thompson E, Landi D, Archer G, Lipp E, Walter A, Archambault B, et al. EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In: Neuro-Oncology. Oxford University Press (OUP); 2021. p. i46–i46.

Thompson, Eric, et al. “EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” Neuro-Oncology, vol. 23, no. Supplement_1, Oxford University Press (OUP), 2021, pp. i46–i46. Manual, doi:10.1093/neuonc/noab090.187.

Thompson E, Landi D, Archer G, Lipp E, Walter A, Archambault B, Balajonda B, Flahiff C, Jaggers D, Herndon J, Buckley E, Schroeder K, Randazzo D, Desjardins A, Johnson M, Peters K, Khasraw M, Malinzak M, Michell D, Ashley D, Sampson J. EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. Neuro-Oncology. Oxford University Press (OUP); 2021. p. i46–i46.